JPS63224702A - ポリプロピレン多孔質膜およびその製造方法 - Google Patents
ポリプロピレン多孔質膜およびその製造方法Info
- Publication number
- JPS63224702A JPS63224702A JP5672887A JP5672887A JPS63224702A JP S63224702 A JPS63224702 A JP S63224702A JP 5672887 A JP5672887 A JP 5672887A JP 5672887 A JP5672887 A JP 5672887A JP S63224702 A JPS63224702 A JP S63224702A
- Authority
- JP
- Japan
- Prior art keywords
- polypropylene
- membrane
- porous membrane
- porous
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 148
- -1 Polypropylene Polymers 0.000 title claims abstract description 122
- 239000004743 Polypropylene Substances 0.000 title claims abstract description 118
- 229920001155 polypropylene Polymers 0.000 title claims abstract description 118
- 238000004519 manufacturing process Methods 0.000 title claims description 28
- 238000001816 cooling Methods 0.000 claims abstract description 40
- 239000011148 porous material Substances 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 230000035699 permeability Effects 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000002344 surface layer Substances 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims description 52
- 239000012766 organic filler Substances 0.000 claims description 33
- 238000007711 solidification Methods 0.000 claims description 30
- 230000008023 solidification Effects 0.000 claims description 30
- 239000003484 crystal nucleating agent Substances 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 15
- 150000008282 halocarbons Chemical class 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 6
- 230000008025 crystallization Effects 0.000 claims description 6
- 239000000155 melt Substances 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 229920000570 polyether Polymers 0.000 claims description 4
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 abstract description 37
- 239000000945 filler Substances 0.000 abstract description 9
- 239000012188 paraffin wax Substances 0.000 abstract description 9
- 239000002202 Polyethylene glycol Substances 0.000 abstract description 5
- 229920001223 polyethylene glycol Polymers 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000000306 component Substances 0.000 description 18
- 210000000601 blood cell Anatomy 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 13
- 229940057995 liquid paraffin Drugs 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 238000000605 extraction Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 206010018910 Haemolysis Diseases 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 230000008588 hemolysis Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229920002301 cellulose acetate Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000635 electron micrograph Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000000110 cooling liquid Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940087101 dibenzylidene sorbitol Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229920001384 propylene homopolymer Polymers 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- AHFMSNDOYCFEPH-UHFFFAOYSA-N 1,2-difluoroethane Chemical compound FCCF AHFMSNDOYCFEPH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241001125929 Trisopterus luscus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- UMNKXPULIDJLSU-UHFFFAOYSA-N dichlorofluoromethane Chemical compound FC(Cl)Cl UMNKXPULIDJLSU-UHFFFAOYSA-N 0.000 description 1
- 229940099364 dichlorofluoromethane Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- UHCBBWUQDAVSMS-UHFFFAOYSA-N fluoroethane Chemical compound CCF UHCBBWUQDAVSMS-UHFFFAOYSA-N 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 239000003779 heat-resistant material Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000009390 immune abnormality Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Separation Using Semi-Permeable Membranes (AREA)
- External Artificial Organs (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5672887A JPS63224702A (ja) | 1987-03-13 | 1987-03-13 | ポリプロピレン多孔質膜およびその製造方法 |
| US07/392,988 US5139529A (en) | 1987-01-20 | 1988-01-20 | Porous polypropylene membrane and methods for production thereof |
| DE3855721T DE3855721T2 (de) | 1987-01-20 | 1988-01-20 | Poröse polypropylenmembran und verfahren zu deren herstellung |
| KR1019880701129A KR940002379B1 (ko) | 1987-01-20 | 1988-01-20 | 폴리프로필렌 다공질막 및 그의 제조방법 |
| AU11847/88A AU623848B2 (en) | 1987-01-20 | 1988-01-20 | Porous polypropylene membrane and process for its production |
| EP88901092A EP0341309B1 (en) | 1987-01-20 | 1988-01-20 | Porous polypropylene membrane and process for its production |
| KR1019940700300A KR940008074B1 (ko) | 1987-01-20 | 1988-01-20 | 폴리프로필렌 다공질막 |
| PCT/JP1988/000039 WO1988005475A1 (en) | 1987-01-20 | 1988-01-20 | Porous polypropylene membrane and process for its production |
| CA000560896A CA1310160C (en) | 1987-03-13 | 1988-03-09 | Porous polypropylene hollow fiber membrane, method for production thereof and artificial lung |
| US07/820,481 US5354470A (en) | 1987-01-20 | 1992-01-14 | Porous polypropylene membrane and method for production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5672887A JPS63224702A (ja) | 1987-03-13 | 1987-03-13 | ポリプロピレン多孔質膜およびその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63224702A true JPS63224702A (ja) | 1988-09-19 |
| JPH0555174B2 JPH0555174B2 (enrdf_load_stackoverflow) | 1993-08-16 |
Family
ID=13035561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5672887A Granted JPS63224702A (ja) | 1987-01-20 | 1987-03-13 | ポリプロピレン多孔質膜およびその製造方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS63224702A (enrdf_load_stackoverflow) |
| CA (1) | CA1310160C (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007061673A (ja) * | 2005-08-29 | 2007-03-15 | Toray Ind Inc | 医用分離膜用微孔性ポリプロピレンシートおよびそれを用いた医用分離膜 |
-
1987
- 1987-03-13 JP JP5672887A patent/JPS63224702A/ja active Granted
-
1988
- 1988-03-09 CA CA000560896A patent/CA1310160C/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007061673A (ja) * | 2005-08-29 | 2007-03-15 | Toray Ind Inc | 医用分離膜用微孔性ポリプロピレンシートおよびそれを用いた医用分離膜 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0555174B2 (enrdf_load_stackoverflow) | 1993-08-16 |
| CA1310160C (en) | 1992-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940002379B1 (ko) | 폴리프로필렌 다공질막 및 그의 제조방법 | |
| KR100991596B1 (ko) | 할라 막 | |
| US4927576A (en) | Method for the manufacture of flat permeable membrane | |
| FR2485943A1 (fr) | Membranes pour la microfiltration, l'ultrafiltration ou la dialyse, a base de copolymeres de methacrylate de methyle | |
| US20040026315A1 (en) | Melt-spun polysulfone semipermeable membranes and methods for making the same | |
| US5186835A (en) | Porous hydrophilic polypropylene membrane, method for production thereof, and blood plasma separation apparatus | |
| RU2198725C2 (ru) | Сформованные из расплава полисульфоновые полупроницаемые мембраны и способы их получения | |
| US4964991A (en) | Flat permeable membrane and for manufacture thereof | |
| JPS5891732A (ja) | ポリフツ化ビニリデン系樹脂多孔膜及びその製法 | |
| JPH0235918A (ja) | ポリプロピレン多孔質中空糸膜およびその製造方法 | |
| JPS63224702A (ja) | ポリプロピレン多孔質膜およびその製造方法 | |
| KR910009814B1 (ko) | 친수성 폴리프로필렌 다공질막, 그의 제조방법 및 혈장 분리장치 | |
| JPS6297603A (ja) | ポリプロピレン多孔質膜およびその製造方法 | |
| JPH0371144B2 (enrdf_load_stackoverflow) | ||
| WO1983001632A1 (en) | Polymethyl methacrylate hollow yarn ultra-filtration membrane and process for its production | |
| JPS61114702A (ja) | 平膜型透過性膜の製造方法 | |
| JPS5958041A (ja) | ポリスルホン多孔膜の製造方法 | |
| JPS6045358A (ja) | 血漿分離膜及びその製造方法 | |
| JPH01228505A (ja) | 多孔質中空糸膜、その製造方法およびその中空糸膜を用いた人工肺 | |
| JPH0474046B2 (enrdf_load_stackoverflow) | ||
| JPH01168303A (ja) | 多孔質中空糸膜およびその製造方法ならびに人工肺 | |
| JPH0512969B2 (enrdf_load_stackoverflow) | ||
| JPH0512970B2 (enrdf_load_stackoverflow) | ||
| JPS6350513A (ja) | 中空繊維の製造方法 | |
| JPH0521617B2 (enrdf_load_stackoverflow) |